Symptomatic hypocalcaemia after treatment with high-dose aminohydroxypropylidene diphosphonate.
D004164:Diphosphonates / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy; D006996:Hypocalcemia / Q000139:chemically induced*; D008875:Middle Aged; D000077268:Pamidronate
D004164:Diphosphonates; D000077268:Pamidronate